Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

FSSAI issues notices to Dr Reddy’s, Nestle Health Science, Amazon, Flipkart for misleading claims

by AIP Online Bureau | Oct 8, 2026 | Eco/Invest/Demography, Indian News, Regulation | 0 comments

The regulator further said that the claims printed on the pack regarding muscle strength, immunity support and energy metabolism were found to be presented in a way that could mislead consumers about the health benefit of the product.

Mumbai: Food regulator Food Safety and Standards Authority of India (FSSAI) has issued notices to Dr Reddy’s, Nestle Health Science, Tirupati Wellness, Flipkart, Amazon and Netmeds for selling health supplement products with misleading claims.

In a social media post on Thursday, the FSSAI said the companies have been directed to explain why action should not be taken against them.

The regulator further said that the claims printed on the pack regarding muscle strength, immunity support and energy metabolism were found to be presented in a way that could mislead consumers about the health benefit of the product.

FSSAI said that the notices have been issued to Dr Reddy’s, Nestle Health Science, Tirupati Wellness Pvt Ltd, Flipkart India, Amazon Seller Services and Netmeds Healthcare regarding non-compliant advertising and claims for product ‘CELEVIDA GLP+’ on e-commerce platforms.

Elaborating, the regulator said that “the product was found to be advertised as ‘high protein support for lean muscle preservation during GLP-1/GIP therapies’, with claims associating its consumption with GLP-1/GIP therapies and preservation of lean muscle.”

Such claims were found to imply suitability for a specific physiological condition, it added.

The brand name ‘Celevida GLP+’, along with the GLP-1/GIP therapy-related claims, was found to create a misleading association between the product and such therapies, it added.

Claims such as ‘Helps Maintain Lean Muscle’, ‘support muscle strength’ and ‘preserve lean mass’ were found to imply that the product might help mitigate loss of lean body mass during weight loss and GLP-1/GIP therapy, the regulator said.

FSSAI said that the product has been marketed as a complete nutrition product.

The representation ‘imported from Europe for purity’ was found to be misleading.

In the last six months, FSSAI has stepped up enforcement actions against food business operators and e-commerce companies.

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • FSSAI issues notices to Dr Reddy’s, Nestle Health Science, Amazon, Flipkart for misleading claims
  • Govt to cap trade margins at 30 pc of MRP for anti-cancer drugs, say sources
  • NMC bars AI-generated patient testimonials, clinical outcomes in medical advertising
  • GST Council allows employers to get Input Tax Credit on GST paid for employee insurance cover
  • PM calls for global framework on cyberfraud, deepfakes; asks govts, telcos, financial cos to team up

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy